Gr Sarantis S A : LISTING OF SHARES DERIVED FROM A SHARE CAPITAL INCREASE
January 13, 2017 at 04:30 am EST
Share
Athens, January 13, 2017
Listing of shares derived from a share capital increase following the exercise of the Company's stock options (stock option plan)
The company GR. SARANTIS S.A. (the Company) hereby announces that, as of TuesdayJanuary 17th 2017, the ten thousand (10,000) new common registered shares of the Company, which derived from a share capital increase due to the exercise of the Company's stock options (stock option plan) by one executive member of the Company, will be subject to negotiation at the Stock Exchange of Athens. The share capital increase was realized through payment in cash, in the amount of fifteen thousand and five hundred euro (euro 15,500) at the acquisition price of 2.00 euros in accordance with the decision of the Repeated General Meeting of the Company's shareholders of 18.07.2001 as this was modified by subsequent General Meetings as well as the Company's Board of Directors' decisions dated October 07th 2016.
The aforementioned increase, which does not constitute a direct amendment of the Company's Articles of Association, was confirmed by the Company's Board of Directors on 16/12/2016, in implementation of the aforementioned decisions and was filed with the Companies Registry with the respective announcement No.881212.
The Athens Stock Exchange, at its meeting of January 12th 2017, approved the listing for trading of the aforementioned 10,000 common registered shares of the Company. As of January 17 2017, the shares of the Company will be subject to negotiation at the Stock Exchange and the starting price will be formed pursuant to the Regulation of the Stock Exchange. As of that same date, the above shares will be credited to the Incorporeal Securities System accounts and the securities accounts of the beneficiaries/shareholders.
For more information, the shareholders are kindly referred to the relevant information report of L.3401/2005, which is available in electronic form at the Athens Stock Exchange site as well as the Company's site (www.sarantis.gr) and in hard copy at the company's premises. Alternatively shareholders can contact the Company's Shareholder Services department (tel. +30 210 6173065).
Athens, January 13, 2017
Gr. Sarantis SA published this content on 13 January 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 13 January 2017 09:30:07 UTC.
Original documenthttp://ir.sarantis.gr/en/news/investors-press?item=1723
Public permalinkhttp://www.publicnow.com/view/C4330EF50959FE9B0C47CEC369B5997BABA0A9B5
Sarantis S.A. is one of the world's leading distributors of branded consumer products. Net sales break down by family of products as follows:
- cosmetic products (42.3%): perfumery and toiletry products (Antonio Banderas, BU, C.THRU, Denim, Elode, Myrto, Noxzema, Prosar, STR8, Tesori l'Oriente and Vidal), skin care products (Astrid, Bioten, Elmiplant and Kolastyna), sun screen products (Carroten, Coppertone and Piz Buint) and hair care products (Final Net and Orzene Beer);
- household products (39.8%): food preservation products (Domet, Fino, Fox, Grosik, Hewa, Jan, Korunka Sanitas and Topstar), home maintenance equipment (Afroso, Ava, Flame, Septifos and Tuboflo), insecticides (Globol, Pyrox and Teza), shoe creams (Camel), etc. ;
- other (12.4%): including health care products, dietary supplements, pregnancy tests, etc.
The remaining net sales (5.5%) are from the manufacturing of plastic packaging products (Label Polipak).
At the end of 2020, the group operated a network of nearly 110,000 sales outlets in Europe.
Net sales are distributed geographically as follows: Greece (34.6%), Poland (23.6%), Romania (14%), Ukraine (7.1%), Czech Republic (5.2%), Serbia (5.1%), Bulgaria (3.3%), Hungary (2.6%) and others (4.5%).
SARANTIS S.A. 
